2-(2-(2-(2-(4-(6-Methyl-1,2,4,5-tetrazin-3-yl)phenoxy)ethoxy)ethoxy)ethoxy)ethanamine hydrochloride, 97%, 250mg

2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 95.0%, 250mg

3-Bromo-6-chloro-7-methylimidazo[1,2-b]pyridazine, 97%, 250mg

4-NITROCINNAMIC ACID, 98%, 5g

1-cyclopropyl-3-phenylpiperazine-2,5-dione, 95.0%, 500mg

N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide, 95%, 100mg

Thianthrene-1-boronic acid, 97.0%, 10g

N'-(4-Bromo-2-cyanophenyl)-N,N-dimethylformamidine>98.0%(GC)(T)1g

Clonidine Hydrochloride>98.0%(HPLC)(T)1g

2-(4-Nitrophenyl)ethanamine, 95.0%, 25g

5-BROMO-7-ETHYL-1H-INDAZOLE, 95%, 100mg

Flacon de réaction à bride plate, cylindrique, gradué, avec enveloppe de trempe, pièce de raccordement KF, DN 150, 5000 ml, 190 mm, 1 pièce

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(6-methoxypyridin-3-yl)propanoic acid, 98%, 100mg